Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 1.11 M1.31 M1.9 M912.78 K 5.23 M Research & development ———— — Operating income -531.17 K-928.73 K-2.19 M-1.01 M -4.65 M Non-Operating Income, Total ———— — Interest expense, net of interest capitalized ———50.43 K — Non-Operating Income, excl. Interest Expenses ———— — Unusual income/expense ———— — Pretax income 2.29 M-986.78 K-2.4 M-1.03 M -2.12 M Equity in earnings ———— — Taxes 483 K13 K-114 K-16 K 366 K Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 1.81 M-999.78 K-2.29 M-1.01 M -2.49 M Discontinued operations ———— — Net income 1.81 M-999.78 K-2.29 M-1.01 M -2.49 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 1.81 M-999.78 K-2.29 M-1.01 M -2.49 M Basic earnings per share (Basic EPS) 0.78-0.43-0.99-0.4 -1.04 Diluted earnings per share (Diluted EPS) 0.78-0.43-0.99-0.4 -1.04 Average basic shares outstanding 2.31 M2.31 M2.31 M2.4 M — Diluted shares outstanding 2.31 M2.31 M2.31 M2.4 M — EBITDA 2.4 M-850.61 K-2.17 M-985.51 K -1.6 M EBIT 2.4 M-852.04 K-2.17 M-985.67 K -1.61 M Cost of revenue 3.13 M300.86 K299.55 K313.26 K 4.04 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 1 6191 4391 255157 —